NCT03839875 - Evaluation of Efficacy and Safety of Gynomax® XL Ovule | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

August 9, 2019

Study Completion Date

August 9, 2019

Conditions

Trichomonal VaginitisBacterial VaginosisCandidal VulvovaginitisMixed Vaginal Infections

Interventions

DRUG

Gynomax® XL Vaginal Ovule

tioconazole, tinidazole, lidocaine

Trial Locations (1)

Ege University Family Planning and Infertility Application and Research Centeraştırma Merkezi, Izmir